From: Clinical significance of polyglutamylation in primary central nervous system lymphoma
 | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
Variable | HR (95% CI) | p | HR (95% CI) | p |
Age | 1.027 (1.002–1.053) | 0.035 | 1.047 (1.005–1.092) | 0.028 |
KPS (high vs. low) | 0.376 (0.182–0.779) | 0.0085 | 0.263 (0.096–0.724) | 0.0097 |
Sex (M vs. F) | 1.096 (0.617–1.945) | 0.75 | 0.712 (0.369–1.374) | 0.31 |
MSKCC score | 1.534 (0.982–2.394) | 0.060 | 0.607 (0.277–1.334) | 0.21 |
Cell of origin (GCB vs. non-GCB) | 0.914 (0.483–1.730) | 0.78 | 1.129 (0.546–2.334) | 0.74 |
LDH (high vs. normal range) | 1.029 (0.563–1.881) | 0.93 | 0.773 (0.391–1.528) | 0.46 |
Location (deep vs. not deep) | 0.796 (0.419–1.514) | 0.49 | 0.603 (0.297–1.226) | 0.16 |
Polyglutamylation vs. non-polyglutamylation | 0.978 (0.557–1.718) | 0.94 | 1.728 (0.716–4.171) | 0.22 |